Surgical management of parathyroid cancer during the COVID-19 pandemic: experience from a tertiary referral centre (a case series)

Abstract

Background: Parathyroid carcinoma is a rare malignancy which accounts for 1% of cases of primary hyperparathyroidism. In patients with severe hypercalcaemia or a significantly raised parathyroid hormone (PTH) level clinicians should consider parathyroid carcinoma and expedited management is essential. During the current pandemic, a high index of suspicion should be maintained to ensure care is not compromised. A review of the management of patients with suspected parathyroid carcinoma during the COVID-19 pandemic is presented.